BNO.AX - Bionomics Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Cash flows from operating activities
Net income
-24,914
-21,759
-8,697
-7,118
-9,669
Depreciation & amortisation
-
1,109
-
-
-
Stock-based compensation
-
2,830
-
-
-
Change in working capital
-
-5,602
-
-
-
Accounts receivable
-
-39.148
-
-
-
Inventory
-
0
-
-
-
Other working capital
-17,927
-21,757
-7,540
-3,911
-15,681
Other non-cash items
-
926.485
-
-
-
Net cash provided by operating activities
-
-21,755
-
-
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-1.544
-1.468
-7.704
-98.927
Acquisitions, net
-
0
-
-1,008
-
Purchases of investments
-
0
-118.466
-52.174
-
Sales/maturities of investments
0
435.64
-
550
-
Other investing activities
-105.57
-
-
497.826
13.93
Net cash used for investing activities
198.488
621.703
-80.206
-195.131
197.652
Cash flows from financing activities
Debt repayment
-154.393
-174.218
-11,087
-7,460
-5,327
Common stock issued
10,228
32,890
43,836
3,260
10,100
Common stock repurchased
-
0
-415.479
-48.228
-420.369
Other financing activities
-3,113
-5,721
-415.479
-329.896
-420.369
Net cash used provided by (used for) financing activities
8,375
26,996
31,554
-5,357
4,352
Net change in cash
-9,352
5,862
23,935
-9,455
-11,032
Cash at beginning of period
40,352
28,499
4,578
13,985
24,930
Cash at end of period
31,000
33,565
28,499
4,578
13,985
Free cash flow
Operating cash flow
-
-21,755
-
-
-
Capital expenditure
-
-1.544
-1.468
-7.704
-98.927
Free cash flow
-17,927
-21,757
-7,540
-3,911
-15,681